In a melanoma preclinical model, CD8+ TILs were found to be metabolically compromised due to a ENO1 post-transcriptional regulation since it was expressed as mRNA and protein level, but ENO1 enzymatic activity was defective [207]. The gene discussed is ENO1; the disease is melanoma.